Retatrutide is still being studied in clinical trials and is not the same as fully approved commercial products
First approved to treat type 2 diabetes, GLP-1 based drugs are now used to aid weight loss in obesity and to help lower the risk of heart failure and treat obstructive sleep apnea, a common breathing-related sleep disorder, in people with obesity
With their low glycemic index, leafy greens and broccoli are excellent for managing Type 2 diabetes or insulin resistance
Other entero-pancreatic hormones and combination of entero-pancreatic hormones in the management of obesity Numerous entero-pancreatic hormones [GIP, glucagon, amylin and peptide YY (PYY) agonists and GIP antagonists] with diverse metabolic actions are currently under investigation either alone or in combination with GLP-1 RA (Fig
Clear value: Transparent pricing instead of paying a premium for supplements
These drugs by increasing insulin secretion and possibly, beta cell mass, decrease plasma glucose and lipids and have a secondary action to reduce food intake and bring about weight loss
